רגולציה ולגלזציה

When I sat down with Rohan Marley ahead of The Whine Down—our cultural benefit experience supporting the Bob & Rita Marley Foundation’s hurricane relief efforts in Jamaica—our conversation moved quickly into the teachings that have shaped his life. Before we talked logistics, food, or philanthropy, he returned to something much older: a lesson from his…

When DOPE® first stepped into cannabis culture, it stood for more than a name. It represented style, advocacy, community and the people who kept the plant alive long before legalization arrived. Now DOPE® is returning with a renewed focus on real connections and culture-forward experiences. As part of this revival, DOPE® is launching a new…

This article is an adapted version of the Cannabis Confidential newsletter.Turnpike TuesdayThe Informant It’s a rare session that I’ll step away from the screens, particularly with so much going on, year-end approaching and the industry on edge. As I pride myself on conducting exhaustive due diligence, I drove across the river this morning to join…

DOPE® is returning with a renewed purpose. High Times and Dope Magazine are relaunching the DOPE® program as an active cultural platform dedicated to community, recognition and cannabis justice. As part of this relaunch, DOPE® and High Timesare presenting the 2025 DOPE® Award, an honor given to individuals whose work reflects leadership, service and meaningful…

Bipartisan House and Senate lawmakers have introduced a bill in Congress to allow doctors to administer Schedule I drugs such as certain psychedelics to patients with life-threatening conditions. The “Freedom to Heal Act”—sponsored by Sens. Cory Booker (D-NJ) and Rand Paul (R-KY), as well as Reps. Madeleine Dean (D-PA) and Nancy Mace (R-SC)—aims to expand…